2020 In Review: US FDA New Drug Office’s COVID-19 Response Aided By Reorganization

 
• By Sue Sutter
Silos. Warehouse storage of the harvest. Field with sunflowers.
The Office of New Drugs' massive restructurting eliminated some organizational silos, which made it easier for staff to work together on responding to the pandemic. • Source: Shutterstock

More from Pink Sheet Perspectives

More from Pink Sheet